PDS Biotechnology Statistics
Total Valuation
PDSB has a market cap or net worth of $74.56 million. The enterprise value is $41.20 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PDSB has 36.82 million shares outstanding. The number of shares has increased by 15.51% in one year.
Current Share Class | 36.82M |
Shares Outstanding | 36.82M |
Shares Change (YoY) | +15.51% |
Shares Change (QoQ) | +0.31% |
Owned by Insiders (%) | 3.76% |
Owned by Institutions (%) | 12.57% |
Float | 35.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.41 |
P/TBV Ratio | 2.41 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.79 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -8.28 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -47.60% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.62M |
Employee Count | 25 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -869,167 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.81% in the last 52 weeks. The beta is 1.93, so PDSB's price volatility has been higher than the market average.
Beta (5Y) | 1.93 |
52-Week Price Change | -67.81% |
50-Day Moving Average | 3.15 |
200-Day Moving Average | 3.60 |
Relative Strength Index (RSI) | 22.81 |
Average Volume (20 Days) | 565,064 |
Short Selling Information
The latest short interest is 4.47 million, so 12.14% of the outstanding shares have been sold short.
Short Interest | 4.47M |
Short Previous Month | 4.80M |
Short % of Shares Out | 12.14% |
Short % of Float | 12.62% |
Short Ratio (days to cover) | 10.47 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -39.37M |
Pretax Income | -45.29M |
Net Income | -40.56M |
EBITDA | -39.31M |
EBIT | -39.37M |
Earnings Per Share (EPS) | -$1.16 |
Full Income Statement Balance Sheet
The company has $57.73 million in cash and $24.38 million in debt, giving a net cash position of $33.36 million or $0.91 per share.
Cash & Cash Equivalents | 57.73M |
Total Debt | 24.38M |
Net Cash | 33.36M |
Net Cash Per Share | $0.91 |
Equity (Book Value) | 30.92M |
Book Value Per Share | 0.84 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PDSB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.51% |
Shareholder Yield | -15.51% |
Earnings Yield | -54.39% |
FCF Yield | n/a |
Analyst Forecast
The average price target for PDSB is $15.00, which is 640.74% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $15.00 |
Price Target Difference | 640.74% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -36.84% |
Stock Forecasts Stock Splits
The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Mar 18, 2019 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |